Practical guideline on obesity care in patients with gastrointestinal and liver diseases

07/12/2023

Patients with chronic gastrointestinal disease such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), celiac disease, gastroesophageal reflux disease (GERD), pancreatitis, and chronic liver disease (CLD) often suffer from obesity because of coincidence (IBD, IBS, celiac disease) or related pathophysiology (GERD, pancreatitis and CLD). It is unclear if such patients need a particular diagnostic and treatment that differs from the needs of lean gastrointestinal patients. The present guideline addresses this question according to current knowledge and evidence.

Objective

The present practical guideline is intended for clinicians and practitioners in general medicine, gastroenterology, surgery and other obesity management, including dietitians and focuses on obesity care in patients with chronic gastrointestinal diseases.

Methods

The present practical guideline is the shortened version of a previously published scientific guideline developed according to the standard operating procedure for ESPEN guidelines. The content has been re-structured and transformed into flow-charts that allow a quick navigation through the text.

Results

In 100 recommendations (3XA,33xB,24×0,40xGPP, all with a consensus grade of 90% or more) care of gastrointestinal patients with obesity e including sarcopenic obesity e is addressed in a multidisciplinary way. A particular emphasis is on CLD, especially metabolic associated liver disease, since such diseases are closely related to obesity, whereas liver cirrhosis is rather associated with sarcopenic obesity. A special chapter is dedicated to obesity care in patients undergoing bariatric surgery. The guideline focuses on adults, not on children, for whom data are scarce. Whether some of the recommendations apply to children must be left to the judgment of the experienced pediatrician.

Conclusion

The present practical guideline offers in a condensed way evidence-based advice how to care for patients with chronic gastrointestinal diseases and concomitant obesity, an increasingly frequent constellation in clinical practice.

Published in the European Society for Clinical Nutrition and Metabolism.

 

Maybe you are interested

F100 Formula – Growth and protection for malnourished children according to recommendations of the World Health Organization (WHO)

Recommended by the World Health Organization (WHO) and the Ministry of Health for use in malnourished children, F100 formula helps...
See more

How the Gut Microbiome Shapes Health: The Role of Gut-Organ Connections

  See more documents here: How the Gut Microbiome Shapes Health The Role of Gut-Organ Connections (PDF)  
See more

The developing immune system – from foetus to toddler

Introduction This article describes the events in the formation of the human immune system and the development of the innate...
See more